Introduction to cardiac neuronal imaging: a clinical perspective.
Procedures for noninvasive and minimally invasive imaging of cardiac neurons and neuronal function using radiolabeled compounds were developed in the second half of the 20th century. The foundation for these procedures was several centuries of research that identified the structural components of the autonomic nervous system and explored the means by which neurotransmitters such as acetylcholine and norepinephrine contributed to neuronal control of target organ effector cells. This article provides a brief clinical overview of modern approaches to the assessment of cardiac neurons as an introduction to the in-depth articles on the current status of cardiac neuronal imaging presented in this supplement.
['Jacobson|Arnold F|AF|', 'Narula|Jagat|J|']
D019797:3-Iodobenzylguanidine D000109:Acetylcholine D000818:Animals D001341:Autonomic Nervous System D003952:Diagnostic Imaging D004285:Dogs D006321:Heart D006801:Humans D009474:Neurons D018377:Neurotransmitter Agents D009638:Norepinephrine D049268:Positron-Emission Tomography D019275:Radiopharmaceuticals D015899:Tomography, Emission-Computed, Single-Photon
cardiac neuronal imaging autonomic nervous system PET SPECT